GDTC

CytoMed Therapeutics (GDTC)

About CytoMed Therapeutics (GDTC)

CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.

Details

Daily high

$1.19

Daily low

$0.97

Price at open

$1.17

52 Week High

$3.68

52 Week Low

$0.73

Market cap

13.7M

Dividend yield

0.00%

Volume

816,896

Avg. volume

1.8M

P/E ratio

-4.87

CytoMed Therapeutics News